Abstract
Understanding the primary steps of viral entry can have important implications for strategies to prevent infection of known viral pathogens as well as determining parameters for efficient gene delivery using viral vectors. Recently, a two-step process for viral infection involving attachment of virus to a primary receptor (coxsackievirus adenovirus receptor and heparan sulfate proteoglycan) and subsequent mediation of virus entry by a co-receptor (αV integrins and HVEM) has been determined for both adenovirus and HSV, respectively 1, 2, 3, 4 . Heparan sulfate proteoglycan serves as a primary attachment receptor for adeno-associated virus type 2 (AAV-2)( ref. 5 ). Here we determined that αVβ5 integrin plays a part in efficient AAV infection. Experiments using the chelating agent EDTA to disrupt integrin function resulted in a corresponding decrease in AAV infection, consistent with the possibility that integrin mediates infection. Viral overlay experiments on purified plasma membrane proteins as well as immunoprecipitated integrin β5 subunit demonstrated that AAV directly associates with the β5 subunit of αVβ5 integrin. Genetically defined cells expressing αVβ5 integrin showed increased susceptibility to AAV infection, demonstrating a biological role of this integrin in AAV infection. Finally, viral binding and internalization studies indicate that αVβ5 integrin is not a primary attachment receptor for AAV-2, but is instead involved in facilitating virus internalization. This study supports the idea that αVβ5 integrin serves as a co-receptor for AAV-2 virions, and should have a substantial effect on the use of AAV vectors in human gene therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout



Similar content being viewed by others
References
Bergelson, J.M. et al. Isolation of a common receptor for coxsackie B viruses and adenovirus 2 and 5. Science 275, 1320– 1323 (1997).
Wicham, T.J., Mathias, P., Cheresh, D.A. & Nemerow, G.R. Integrins αVβ3 and αVβ5 promote adenovirus internalization but not virus attachmemt. Cell 73, 309– 319 (1993).
Montgomery, R.I., Warner, M.S., Lum, B.J. & Spear, P.G. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87, 427–436 (1996).
Sheih, M., Montgomery, R.I., Esko, J.D. & Spear, P. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol. 116, 1273– 1281 (1992).
Summerford, C. & Samulski, R.J. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72, 1438–1445 (1998).
Dedhar, S. & Hannigan, G.E. Integrin cytoplasmic interactions and bidirectional transmembrane signalling. Curr. Opin. Cell Biol. 8, 657–669 ( 1996).
Gavrilovskaya, I.N., Shepley, M., Shaw, R., Ginsberg, M.H. & Macow, E.R. β3 integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc. Natl. Acad. Sci. USA 95, 7074–7079 (1998).
Wicham, T.J., Filardo, E.J., Cheresh, D.A. & Nemerow, G.R. Integrin αVβ5 selectively promotes adenovirus mediated cell membrane permeabilization. J. Cell Biol. 127, 257 –264 (1994).
Goldman, M., Su, Q. & Wilson, J.M. Gradient of RGD-dependent entry of adenoviral vector in nasal and intrapulmonary epethelia: implications for gene therapy of cystic fibrosis. Gene Ther. 3, 811– 818 (1996).
Goldman, M.J. & Wilson, J.M. Expression of αVβ5 integrin is necessary for efficient adenovirus-mediated gene transfer in human airway. J. Virol. 69, 5951–5958 (1995).
Svensson, U. & Persson, R. Entry of adenovirus 2 into Hela cells. J. Virol 51, 687– 694 (1984).
Ramaswamy, H. & Hemler, M. Cloning, primary structure and properties of a novel integrin β subunit. EMBO J. 9, 1561–1568 (1990).
Pasqualini, R., Bodorova, J., Ye, S. & Hemeler, M.E. A study of structure, function, and distribution of β5 integrins using anti-β5 monoclonal antibodies. J. Cell Sci. 105, 101– 111 (1993).
Vogel, B.E. et al. A novel integrin specificity exemplified by binding of the αVβ5 integrin to the basic domain of the HIV Tat protein and vitronectin. J. Cell Biol. 121, 461–468 (1993).
Ferrari, F.K., Samulski, T., Shenk, T. & Samulski, R.J. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 7, 3277–3234 (1996).
Xiao, X., Li, J. & Samulski, R.J. Production of high titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol 72, 2224–2232 (1998).
Fisher, K.J. et al. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70, 520–532 (1996).
Pickles, R.J., D. McCarty, H.M., Hart, P.J., Randell, S.H. & Boucher, R.C. Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for efficient gene transfer. J. Virol. 72, 6014–6023 (1998).
Teramoto, S. et al. Factors influencing adeno-associated virus-mediated gene transfer to human cystic fibrosis airway epithelial cells: comparison with adenovirus vectors. J. Virol. 72, 8904– 8912 (1998).
Hashimoto, Y. et al. Efficient transfer of genes into senescent cells by adenovirus vectors via highly expressed alpha v beta 5 integrin. Biochem. Biophys. Res. Com. 240, 88–92 (1997).
Takayama, K. et al. The levels of integrin alph v beta 5 may predict the susceptibility to adenovirus-mediated gene transfer into human lung cancer cells. Gene Ther. 5, 361–368 ( 1998).
Huang, S., Endo, R.I. & Nemerow, G. Upregulation of integrins αVβ3 and αVβ5 on human monocytes and T lymphocytes facilitate adenovirus-mediated gene delivery. J. Virol. 69, 2257–2263 (1995).
Croyle, M.A., Walter, E., Janich, S., Roessler, B. & Amidon, G. Role of integrin expression in adenovirus-mediated gene delivery to the intestinal epithelium. Hum. Gene. Ther. 9, 561–573 (1998).
Geraghty, R.J., Krummenacher, C., Cohen, G.H., Eisenberg, R.J. & Spear, P.G. Entry of alphaherpesviruses mediated by poliovirus-receptor related protein and polivirus receptor. Science 280, 1618–1620 ( 1998).
Qing, K. et al. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nature Med. 5, 71–77 (1999).
Snyder, R.O., Xiao, X. & Samulski, R.J. in Current protocols in human genetics (eds. Dracopoli, N. et al.) 12.11.11-12.12.23 (John Wiley & Sons, New York, 1996).
Bartlett, J.S., Samulski, R.J. & McCown, T.J. Selective and rapid uptake of adeno-associated virus type 2 (AAV-2) in brain. Hum. Gene Ther. 9, 1181–1186 (1998).
Hennache, B. & Boulanger, P. Biochemical study of KB-cell receptor for Adenovirus. Biochem. J. 166, 237– 247 (1977).
Widnell, C.C. & Unkeless, J.C. Partial purification of a lipoprotein with 5'-nucleotidase activity from membranes of rat liver cells. Biochemistry 61, 1050–1057 (1968).
Acknowledgements
We acknowledge F. Ferrari and X. Xiao for their technical help with the adenovirus-free production system. This work was supported in part by NIH-grants NHLBI 539490, 533016 and CF foundation grant MARZLU 96PO.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Summerford, C., Bartlett, J. & Samulski, R. αVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med 5, 78–82 (1999). https://doi.org/10.1038/4768
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/4768
This article is cited by
-
Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters
Gene Therapy (2023)
-
Intracellular trafficking of adeno-associated virus (AAV) vectors: challenges and future directions
Gene Therapy (2021)
-
Vector uncoating limits adeno-associated viral vector-mediated transduction of human dendritic cells and vector immunogenicity
Scientific Reports (2019)
-
Polarized AAVR expression determines infectivity by AAV gene therapy vectors
Gene Therapy (2019)
-
Recent progress and considerations for AAV gene therapies targeting the central nervous system
Journal of Neurodevelopmental Disorders (2018)


